JP3920341B2 - 相乗作用除草剤混合物 - Google Patents
相乗作用除草剤混合物 Download PDFInfo
- Publication number
- JP3920341B2 JP3920341B2 JP51856597A JP51856597A JP3920341B2 JP 3920341 B2 JP3920341 B2 JP 3920341B2 JP 51856597 A JP51856597 A JP 51856597A JP 51856597 A JP51856597 A JP 51856597A JP 3920341 B2 JP3920341 B2 JP 3920341B2
- Authority
- JP
- Japan
- Prior art keywords
- rate
- distributed
- mixture
- seen
- experiment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims description 72
- 230000002363 herbicidal effect Effects 0.000 title claims description 12
- 239000004009 herbicide Substances 0.000 title claims description 6
- 230000002195 synergetic effect Effects 0.000 title description 7
- -1 3-Chloro-4,5,6,7-tetrahydropyrazolo- [1,5-a] -pyridin-2-yl Chemical group 0.000 claims description 19
- 241000196324 Embryophyta Species 0.000 claims description 11
- LLQPHQFNMLZJMP-UHFFFAOYSA-N Fentrazamide Chemical compound N1=NN(C=2C(=CC=CC=2)Cl)C(=O)N1C(=O)N(CC)C1CCCCC1 LLQPHQFNMLZJMP-UHFFFAOYSA-N 0.000 claims description 7
- ZOMSMJKLGFBRBS-UHFFFAOYSA-N bentazone Chemical compound C1=CC=C2NS(=O)(=O)N(C(C)C)C(=O)C2=C1 ZOMSMJKLGFBRBS-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000005476 Bentazone Substances 0.000 claims description 5
- BXEHUCNTIZGSOJ-UHFFFAOYSA-N Esprocarb Chemical compound CC(C)C(C)N(CC)C(=O)SCC1=CC=CC=C1 BXEHUCNTIZGSOJ-UHFFFAOYSA-N 0.000 claims description 5
- UWVKRNOCDUPIDM-UHFFFAOYSA-N Ethoxysulfuron Chemical compound CCOC1=CC=CC=C1OS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 UWVKRNOCDUPIDM-UHFFFAOYSA-N 0.000 claims description 5
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- UNLYSVIDNRIVFJ-UHFFFAOYSA-N Piperophos Chemical compound CCCOP(=S)(OCCC)SCC(=O)N1CCCCC1C UNLYSVIDNRIVFJ-UHFFFAOYSA-N 0.000 claims description 5
- YLPGTOIOYRQOHV-UHFFFAOYSA-N Pretilachlor Chemical compound CCCOCCN(C(=O)CCl)C1=C(CC)C=CC=C1CC YLPGTOIOYRQOHV-UHFFFAOYSA-N 0.000 claims description 5
- QHTQREMOGMZHJV-UHFFFAOYSA-N Thiobencarb Chemical compound CCN(CC)C(=O)SCC1=CC=C(Cl)C=C1 QHTQREMOGMZHJV-UHFFFAOYSA-N 0.000 claims description 5
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzidamine Natural products C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 claims description 5
- WZDDLAZXUYIVMU-UHFFFAOYSA-N bromobutide Chemical compound CC(C)(C)C(Br)C(=O)NC(C)(C)C1=CC=CC=C1 WZDDLAZXUYIVMU-UHFFFAOYSA-N 0.000 claims description 5
- HKPHPIREJKHECO-UHFFFAOYSA-N butachlor Chemical compound CCCCOCN(C(=O)CCl)C1=C(CC)C=CC=C1CC HKPHPIREJKHECO-UHFFFAOYSA-N 0.000 claims description 5
- DEDOPGXGGQYYMW-UHFFFAOYSA-N molinate Chemical compound CCSC(=O)N1CCCCCC1 DEDOPGXGGQYYMW-UHFFFAOYSA-N 0.000 claims description 5
- ASRAWSBMDXVNLX-UHFFFAOYSA-N pyrazolynate Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=O)C=1C(C)=NN(C)C=1OS(=O)(=O)C1=CC=C(C)C=C1 ASRAWSBMDXVNLX-UHFFFAOYSA-N 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- PQTBTIFWAXVEPB-UHFFFAOYSA-N sulcotrione Chemical compound ClC1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O PQTBTIFWAXVEPB-UHFFFAOYSA-N 0.000 claims description 5
- 239000005472 Bensulfuron methyl Substances 0.000 claims description 4
- SUSRORUBZHMPCO-UHFFFAOYSA-N MC-4379 Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC(OC=2C(=CC(Cl)=CC=2)Cl)=C1 SUSRORUBZHMPCO-UHFFFAOYSA-N 0.000 claims description 4
- CHNUNORXWHYHNE-UHFFFAOYSA-N Oxadiazon Chemical compound C1=C(Cl)C(OC(C)C)=CC(N2C(OC(=N2)C(C)(C)C)=O)=C1Cl CHNUNORXWHYHNE-UHFFFAOYSA-N 0.000 claims description 4
- BGNQYGRXEXDAIQ-UHFFFAOYSA-N Pyrazosulfuron-ethyl Chemical group C1=NN(C)C(S(=O)(=O)NC(=O)NC=2N=C(OC)C=C(OC)N=2)=C1C(=O)OCC BGNQYGRXEXDAIQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000005618 Sulcotrione Substances 0.000 claims description 4
- WHKUVVPPKQRRBV-UHFFFAOYSA-N Trasan Chemical compound CC1=CC(Cl)=CC=C1OCC(O)=O WHKUVVPPKQRRBV-UHFFFAOYSA-N 0.000 claims description 4
- XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical group COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 claims description 4
- HFEJHAAIJZXXRE-UHFFFAOYSA-N cafenstrole Chemical compound CCN(CC)C(=O)N1C=NC(S(=O)(=O)C=2C(=CC(C)=CC=2C)C)=N1 HFEJHAAIJZXXRE-UHFFFAOYSA-N 0.000 claims description 4
- XIGAUIHYSDTJHW-UHFFFAOYSA-N mefenacet Chemical compound N=1C2=CC=CC=C2SC=1OCC(=O)N(C)C1=CC=CC=C1 XIGAUIHYSDTJHW-UHFFFAOYSA-N 0.000 claims description 4
- CHIFOSRWCNZCFN-UHFFFAOYSA-N pendimethalin Chemical compound CCC(CC)NC1=C([N+]([O-])=O)C=C(C)C(C)=C1[N+]([O-])=O CHIFOSRWCNZCFN-UHFFFAOYSA-N 0.000 claims description 4
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 claims description 4
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 claims description 3
- 239000005484 Bifenox Substances 0.000 claims description 3
- 239000005574 MCPA Substances 0.000 claims description 3
- 239000005591 Pendimethalin Substances 0.000 claims description 3
- 239000005567 Imazosulfuron Substances 0.000 claims description 2
- NAGRVUXEKKZNHT-UHFFFAOYSA-N Imazosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2N3C=CC=CC3=NC=2Cl)=N1 NAGRVUXEKKZNHT-UHFFFAOYSA-N 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000002474 experimental method Methods 0.000 description 43
- 238000002156 mixing Methods 0.000 description 29
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 20
- 239000013543 active substance Substances 0.000 description 9
- 238000003892 spreading Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- NXQDBZGWYSEGFL-UHFFFAOYSA-N Anilofos Chemical compound COP(=S)(OC)SCC(=O)N(C(C)C)C1=CC=C(Cl)C=C1 NXQDBZGWYSEGFL-UHFFFAOYSA-N 0.000 description 4
- OFSLKOLYLQSJPB-UHFFFAOYSA-N Cyclosulfamuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)NC=2C(=CC=CC=2)C(=O)C2CC2)=N1 OFSLKOLYLQSJPB-UHFFFAOYSA-N 0.000 description 4
- LVKTWOXHRYGDMM-UHFFFAOYSA-N Naproanilide Chemical compound C=1C=C2C=CC=CC2=CC=1OC(C)C(=O)NC1=CC=CC=C1 LVKTWOXHRYGDMM-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000234653 Cyperus Species 0.000 description 3
- 244000058871 Echinochloa crus-galli Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 235000011999 Panicum crusgalli Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- QMTNOLKHSWIQBE-FGTMMUONSA-N exo-(+)-cinmethylin Chemical compound O([C@H]1[C@]2(C)CC[C@@](O2)(C1)C(C)C)CC1=CC=CC=C1C QMTNOLKHSWIQBE-FGTMMUONSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- FFSSWMQPCJRCRV-UHFFFAOYSA-N quinclorac Chemical compound ClC1=CN=C2C(C(=O)O)=C(Cl)C=CC2=C1 FFSSWMQPCJRCRV-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- JDWQITFHZOBBFE-UHFFFAOYSA-N Benzofenap Chemical compound C=1C=C(Cl)C(C)=C(Cl)C=1C(=O)C=1C(C)=NN(C)C=1OCC(=O)C1=CC=C(C)C=C1 JDWQITFHZOBBFE-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 244000275012 Sesbania cannabina Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- WHOZNOZYMBRCBL-OUKQBFOZSA-N (2E)-2-Tetradecenal Chemical compound CCCCCCCCCCC\C=C\C=O WHOZNOZYMBRCBL-OUKQBFOZSA-N 0.000 description 1
- BDQWWOHKFDSADC-UHFFFAOYSA-N 2-(2,4-dichloro-3-methylphenoxy)-n-phenylpropanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C)OC1=CC=C(Cl)C(C)=C1Cl BDQWWOHKFDSADC-UHFFFAOYSA-N 0.000 description 1
- 241000219144 Abutilon Species 0.000 description 1
- 241000209136 Agropyron Species 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 241000748223 Alisma Species 0.000 description 1
- 241000743985 Alopecurus Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000219318 Amaranthus Species 0.000 description 1
- 241001666377 Apera Species 0.000 description 1
- 235000005781 Avena Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- QGQSRQPXXMTJCM-UHFFFAOYSA-N Benfuresate Chemical compound CCS(=O)(=O)OC1=CC=C2OCC(C)(C)C2=C1 QGQSRQPXXMTJCM-UHFFFAOYSA-N 0.000 description 1
- 241000611157 Brachiaria Species 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000209200 Bromus Species 0.000 description 1
- 241000320316 Carduus Species 0.000 description 1
- 241000219312 Chenopodium Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- WMLPCIHUFDKWJU-UHFFFAOYSA-N Cinosulfuron Chemical compound COCCOC1=CC=CC=C1S(=O)(=O)NC(=O)NC1=NC(OC)=NC(OC)=N1 WMLPCIHUFDKWJU-UHFFFAOYSA-N 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 241000207892 Convolvulus Species 0.000 description 1
- VYNOULHXXDFBLU-UHFFFAOYSA-N Cumyluron Chemical compound C=1C=CC=CC=1C(C)(C)NC(=O)NCC1=CC=CC=C1Cl VYNOULHXXDFBLU-UHFFFAOYSA-N 0.000 description 1
- NNYRZQHKCHEXSD-UHFFFAOYSA-N Daimuron Chemical compound C1=CC(C)=CC=C1NC(=O)NC(C)(C)C1=CC=CC=C1 NNYRZQHKCHEXSD-UHFFFAOYSA-N 0.000 description 1
- 241000208296 Datura Species 0.000 description 1
- 235000017896 Digitaria Nutrition 0.000 description 1
- 241001303487 Digitaria <clam> Species 0.000 description 1
- 241000192043 Echinochloa Species 0.000 description 1
- 241000169203 Eichhornia Species 0.000 description 1
- 241000202829 Eleocharis Species 0.000 description 1
- 235000007351 Eleusine Nutrition 0.000 description 1
- 241000209215 Eleusine Species 0.000 description 1
- PQKBPHSEKWERTG-UHFFFAOYSA-N Fenoxaprop ethyl Chemical group C1=CC(OC(C)C(=O)OCC)=CC=C1OC1=NC2=CC=C(Cl)C=C2O1 PQKBPHSEKWERTG-UHFFFAOYSA-N 0.000 description 1
- 241001290564 Fimbristylis Species 0.000 description 1
- 241000748465 Galinsoga Species 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 241000169108 Hydrothrix Species 0.000 description 1
- 241000520028 Lamium Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 241000064140 Lindernia Species 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- 235000017945 Matricaria Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 240000005852 Mimosa quadrivalvis Species 0.000 description 1
- 235000003990 Monochoria hastata Nutrition 0.000 description 1
- 240000000178 Monochoria vaginalis Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000005588 Oxadiazon Substances 0.000 description 1
- 241000209117 Panicum Species 0.000 description 1
- 235000006443 Panicum miliaceum subsp. miliaceum Nutrition 0.000 description 1
- 235000009037 Panicum miliaceum subsp. ruderale Nutrition 0.000 description 1
- 241000209048 Poa Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241000219295 Portulaca Species 0.000 description 1
- 241000722195 Potamogeton Species 0.000 description 1
- 241000341978 Rotala Species 0.000 description 1
- 240000009132 Sagittaria sagittifolia Species 0.000 description 1
- 241000202758 Scirpus Species 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- 235000005775 Setaria Nutrition 0.000 description 1
- 241000232088 Setaria <nematode> Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000220261 Sinapis Species 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 241000488874 Sonchus Species 0.000 description 1
- 240000006694 Stellaria media Species 0.000 description 1
- 241000219422 Urtica Species 0.000 description 1
- 240000005592 Veronica officinalis Species 0.000 description 1
- 241001506766 Xanthium Species 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 150000008107 benzenesulfonic acids Chemical class 0.000 description 1
- RYAGRZNBULDMBW-UHFFFAOYSA-L calcium;3-(2-hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulfonatopropyl)phenoxy]propane-1-sulfonate Chemical compound [Ca+2].COC1=CC=CC(CC(CS([O-])(=O)=O)OC=2C(=CC(CCCS([O-])(=O)=O)=CC=2)OC)=C1O RYAGRZNBULDMBW-UHFFFAOYSA-L 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- BWUPSGJXXPATLU-UHFFFAOYSA-N dimepiperate Chemical compound C=1C=CC=CC=1C(C)(C)SC(=O)N1CCCCC1 BWUPSGJXXPATLU-UHFFFAOYSA-N 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- XITQUSLLOSKDTB-UHFFFAOYSA-N nitrofen Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=CC=C(Cl)C=C1Cl XITQUSLLOSKDTB-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 229940044654 phenolsulfonic acid Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- LFULEKSKNZEWOE-UHFFFAOYSA-N propanil Chemical compound CCC(=O)NC1=CC=C(Cl)C(Cl)=C1 LFULEKSKNZEWOE-UHFFFAOYSA-N 0.000 description 1
- FKERUJTUOYLBKB-UHFFFAOYSA-N pyrazoxyfen Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=O)C=1C(C)=NN(C)C=1OCC(=O)C1=CC=CC=C1 FKERUJTUOYLBKB-UHFFFAOYSA-N 0.000 description 1
- VTRWMTJQBQJKQH-UHFFFAOYSA-N pyributicarb Chemical compound COC1=CC=CC(N(C)C(=S)OC=2C=C(C=CC=2)C(C)(C)C)=N1 VTRWMTJQBQJKQH-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- MGLWZSOBALDPEK-UHFFFAOYSA-N simetryn Chemical compound CCNC1=NC(NCC)=NC(SC)=N1 MGLWZSOBALDPEK-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19544393A DE19544393A1 (de) | 1995-11-15 | 1995-11-15 | Synergistische herbizide Mischungen |
| DE19544393.4 | 1995-11-15 | ||
| PCT/EP1996/004935 WO1997017852A1 (de) | 1995-11-15 | 1996-11-12 | Synergistische herbizide mischungen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000500445A JP2000500445A (ja) | 2000-01-18 |
| JP2000500445A5 JP2000500445A5 (OSRAM) | 2004-10-14 |
| JP3920341B2 true JP3920341B2 (ja) | 2007-05-30 |
Family
ID=7778639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51856597A Expired - Lifetime JP3920341B2 (ja) | 1995-11-15 | 1996-11-12 | 相乗作用除草剤混合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6013605A (OSRAM) |
| EP (1) | EP0863705B1 (OSRAM) |
| JP (1) | JP3920341B2 (OSRAM) |
| KR (1) | KR100427960B1 (OSRAM) |
| CN (1) | CN1084148C (OSRAM) |
| AU (1) | AU711841B2 (OSRAM) |
| BR (1) | BR9611478A (OSRAM) |
| CA (1) | CA2236592C (OSRAM) |
| DE (2) | DE19544393A1 (OSRAM) |
| ES (1) | ES2178720T3 (OSRAM) |
| MX (1) | MX9803824A (OSRAM) |
| MY (1) | MY114731A (OSRAM) |
| RU (1) | RU2170017C2 (OSRAM) |
| TR (1) | TR199800794T2 (OSRAM) |
| TW (1) | TW355125B (OSRAM) |
| UA (1) | UA48203C2 (OSRAM) |
| WO (1) | WO1997017852A1 (OSRAM) |
| ZA (1) | ZA969564B (OSRAM) |
Families Citing this family (255)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19836684A1 (de) * | 1998-08-13 | 2000-02-17 | Hoechst Schering Agrevo Gmbh | Herbizide Mittel für tolerante oder resistente Reiskulturen |
| KR100338621B1 (ko) * | 2000-01-24 | 2002-05-30 | 전광술 | 제초제 및 그 제조방법 |
| US20070160576A1 (en) | 2001-06-05 | 2007-07-12 | Genentech, Inc. | IL-17A/F heterologous polypeptides and therapeutic uses thereof |
| EP2000545B1 (en) | 2001-06-20 | 2011-08-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of lung tumor |
| DE50207026D1 (de) | 2001-08-23 | 2006-07-06 | Bayer Cropscience Sa | Substituierte propargylamine |
| EP2153843B1 (en) | 2001-09-18 | 2012-08-15 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US20030228305A1 (en) | 2002-01-02 | 2003-12-11 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| KR100429139B1 (ko) * | 2002-02-28 | 2004-04-29 | 한국화학연구원 | 싸이할로호프와 메타미호프를 유효성분으로 하는 제초제조성물 및 이를 이용하여 화본과 잡초를 방제하는 방법 |
| MXPA04010092A (es) | 2002-04-16 | 2004-12-13 | Genentech Inc | Composiciones y metodos para el diagnostico y tratamiento de tumores. |
| EP2305710A3 (en) | 2002-06-03 | 2013-05-29 | Genentech, Inc. | Synthetic antibody phage libraries |
| RU2332986C2 (ru) | 2003-04-04 | 2008-09-10 | Дженентек, Инк. | Высококонцентрированные композиции антител и белков |
| US6849579B2 (en) * | 2003-06-25 | 2005-02-01 | Pbi Gordon Corporation | Synergistic quinclorac herbicidal compositions |
| CA2530284A1 (en) | 2003-07-08 | 2005-02-03 | Genentech, Inc. | Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| ES2472690T3 (es) | 2003-11-17 | 2014-07-02 | Genentech, Inc. | Anticuerpo contra CD22 para el tratamiento de tumores de origen hematopoy�tico |
| JP4570890B2 (ja) * | 2004-03-26 | 2010-10-27 | 協友アグリ株式会社 | 除草剤組成物 |
| US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| BRPI0518104B8 (pt) | 2005-01-21 | 2021-05-25 | Genentech Inc | artigo industrializado e uso de anticorpo her2 |
| US20090136505A1 (en) | 2005-02-23 | 2009-05-28 | Johanna Bentz | Intranasal Administration of Active Agents to the Central Nervous System |
| CA2598666A1 (en) | 2005-02-23 | 2006-08-31 | Alza Corporation | Intranasal administration of active agents to the central nervous system |
| CN101163503B (zh) | 2005-02-23 | 2013-05-08 | 健泰科生物技术公司 | 使用her二聚化抑制剂在癌症患者中延长病情进展前时间或存活 |
| EP1853294A4 (en) | 2005-03-03 | 2010-01-27 | Covx Technologies Ireland Ltd | ANTIANGIOGENIC COMPOUNDS |
| WO2006132788A2 (en) | 2005-06-06 | 2006-12-14 | Genentech, Inc. | Transgenic models for different genes and their use for gene characterization |
| AU2006280321A1 (en) | 2005-08-15 | 2007-02-22 | Genentech, Inc. | Gene disruptions, compositions and methods relating thereto |
| CA2630432A1 (en) | 2005-11-21 | 2007-07-19 | Genentech, Inc. | Novel gene disruptions, compositions and methods relating thereto |
| US20080311107A1 (en) | 2006-02-17 | 2008-12-18 | Genetech, Inc. | Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| JP5298007B2 (ja) | 2006-03-21 | 2013-09-25 | ジェネンテック， インコーポレイテッド | アルファ５ベータ１アンタゴニストを含むコンビナトリアル療法 |
| WO2007126455A2 (en) | 2006-04-05 | 2007-11-08 | Genentech, Inc. | Method for using boc/cdo to modulate hedgehog signaling |
| EP2082645A1 (en) | 2006-04-19 | 2009-07-29 | Genentech, Inc. | Novel gene disruptions, compositions and methods relating thereto |
| JP2009539384A (ja) | 2006-06-06 | 2009-11-19 | ジェネンテック・インコーポレーテッド | 抗ｄｌｌ４抗体および抗ｄｌｌ４抗体使用の方法 |
| US8874380B2 (en) | 2010-12-09 | 2014-10-28 | Rutgers, The State University Of New Jersey | Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs |
| WO2008021290A2 (en) | 2006-08-09 | 2008-02-21 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
| DK2059533T3 (da) | 2006-08-30 | 2013-02-25 | Genentech Inc | Multispecifikke antistoffer |
| EP2089425B1 (en) | 2006-11-10 | 2011-08-17 | CovX Technologies Ireland Limited | Anti-angiogenic compounds |
| BRPI0807635A2 (pt) | 2007-02-22 | 2014-06-03 | Genentech Inc | Métodos para detecção de doença inflamatória intestinal |
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| CA3006428A1 (en) | 2007-06-08 | 2008-12-18 | Genentech, Inc. | Gene expression markers of tumor resistance to her2 inhibitor treatment |
| RU2557319C2 (ru) | 2007-07-16 | 2015-07-20 | Дженентек, Инк. | ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА ПРОТИВ CD79b И ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ПРИМЕНЕНИЯ |
| ES2381788T3 (es) | 2007-07-16 | 2012-05-31 | Genentech, Inc. | Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso |
| CN101910414B (zh) | 2007-11-07 | 2016-01-13 | 健泰科生物技术公司 | 用于评估b细胞淋巴瘤对抗cd40抗体治疗的响应性的方法和组合物 |
| JP4932940B2 (ja) | 2007-11-12 | 2012-05-16 | セラクローン サイエンシーズ， インコーポレイテッド | インフルエンザの治療および診断のための組成物および方法 |
| HUE029869T2 (en) | 2008-01-31 | 2017-04-28 | Genentech Inc | Anti-cd79b antibodies and immunoconjugates and methods of use |
| US7982012B2 (en) | 2008-03-10 | 2011-07-19 | Theraclone Sciences, Inc. | Compositions and methods for the therapy and diagnosis of cytomegalovirus |
| US20110123530A1 (en) | 2008-03-31 | 2011-05-26 | Arron Joseph R | Compositions and methods for treating and diagnosing asthma |
| CN102124344B (zh) | 2008-05-16 | 2015-04-01 | 霍夫曼-拉罗奇有限公司 | 生物标记用于评估β7整联蛋白拮抗剂治疗胃肠道炎性病症的用途 |
| EP2899211A1 (en) | 2008-07-08 | 2015-07-29 | OncoMed Pharmaceuticals, Inc. | Notch1 receptor binding agents and methods of use thereof |
| DK2318832T3 (da) | 2008-07-15 | 2014-01-20 | Academia Sinica | Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder |
| CN101352171B (zh) * | 2008-09-19 | 2012-07-04 | 北京燕化永乐农药有限公司 | 吡嘧磺隆与甲羧除草醚农药的除草剂组合物 |
| CN102215869B (zh) | 2008-11-13 | 2015-05-13 | 通用医疗公司 | 用于通过调整bmp-6来调节铁稳态的方法和组合物 |
| WO2010062857A1 (en) | 2008-11-26 | 2010-06-03 | Allergan, Inc. | Klk-13 antibody inhibitor for treating dry eye |
| CA3120172A1 (en) | 2008-12-09 | 2010-07-08 | Genentech, Inc. | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| SI3260136T1 (sl) | 2009-03-17 | 2021-05-31 | Theraclone Sciences, Inc. | Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa |
| JP5624114B2 (ja) | 2009-03-20 | 2014-11-12 | ジェネンテック， インコーポレイテッド | 抗ｈｅｒ抗体 |
| SG174992A1 (en) | 2009-04-01 | 2011-11-28 | Genentech Inc | Anti-fcrh5 antibodies and immunoconjugates and methods of use |
| WO2010114859A1 (en) | 2009-04-01 | 2010-10-07 | Genentech, Inc. | Treatment of insulin-resistant disorders |
| US20100297127A1 (en) | 2009-04-08 | 2010-11-25 | Ghilardi Nico P | Use of il-27 antagonists to treat lupus |
| EP2419531B1 (en) | 2009-04-18 | 2016-09-07 | Genentech, Inc. | Methods for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies |
| CN102459340A (zh) | 2009-04-23 | 2012-05-16 | 特罗科隆科学有限公司 | 粒性白血细胞-巨噬细胞菌落-刺激因子(gm-csf)中和抗体 |
| US8858948B2 (en) | 2009-05-20 | 2014-10-14 | Theraclone Sciences, Inc. | Compositions and methods for the therapy and diagnosis of influenza |
| WO2011019679A1 (en) | 2009-08-11 | 2011-02-17 | Allergan, Inc. | Ccr2 inhibitors for treating conditions of the eye |
| CN102711826B (zh) | 2009-10-22 | 2017-03-29 | 霍夫曼-拉罗奇有限公司 | 用于调控巨噬细胞刺激性蛋白的hepsin活化的方法和组合物 |
| WO2011056497A1 (en) | 2009-10-26 | 2011-05-12 | Genentech, Inc. | Activin receptor type iib compositions and methods of use |
| WO2011056502A1 (en) | 2009-10-26 | 2011-05-12 | Genentech, Inc. | Bone morphogenetic protein receptor type ii compositions and methods of use |
| WO2011056494A1 (en) | 2009-10-26 | 2011-05-12 | Genentech, Inc. | Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations |
| DK2494356T3 (en) | 2009-10-26 | 2017-05-15 | Genentech Inc | ASSAYS FOR THE DETECTION OF ANTIBODIES SPECIFIC TO THERAPEUTIC ANTI-IGE ANTIBODIES AND THEIR USE OF ANAPHYLAXY |
| SG10201408599QA (en) | 2009-11-30 | 2015-02-27 | Genentech Inc | Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 ) |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| WO2011082187A1 (en) | 2009-12-30 | 2011-07-07 | Genentech, Inc. | Methods for modulating a pdgf-aa mediated biological response |
| BR112012020373A8 (pt) | 2010-02-23 | 2018-01-02 | Genentech Inc | anticorpo isolado, célula, ácido nucleico isolado, método de identificação, de inibição da proliferação de uma célula, de tratamento terapêutico, de determinação da presença de uma proteína tat419, de diagnóstico da presença de câncer e de distribuição de agente citotóxico |
| US10338069B2 (en) | 2010-04-12 | 2019-07-02 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| WO2011133931A1 (en) | 2010-04-22 | 2011-10-27 | Genentech, Inc. | Use of il-27 antagonists for treating inflammatory bowel disease |
| JP2013525484A (ja) | 2010-05-03 | 2013-06-20 | ジェネンテック， インコーポレイテッド | タンパク質含有製剤の粘度を低減させるために有用な組成物及び方法 |
| CN103068378B (zh) | 2010-05-10 | 2016-07-06 | 中央研究院 | 具有抗流感活性的扎那米韦膦酸酯同类物及其制备方法 |
| CN102265853A (zh) * | 2010-06-04 | 2011-12-07 | 南京华洲药业有限公司 | 一种含灭草松和二氯喹啉酸的除草组合物及其应用 |
| US20110311527A1 (en) | 2010-06-16 | 2011-12-22 | Allergan, Inc. | IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS |
| EP2420250A1 (en) | 2010-08-13 | 2012-02-22 | Universitätsklinikum Münster | Anti-Syndecan-4 antibodies |
| AU2011289275A1 (en) | 2010-08-12 | 2013-02-21 | Theraclone Sciences, Inc. | Anti-hemagglutinin antibody compositions and methods of use thereof |
| JP2013537416A (ja) | 2010-08-13 | 2013-10-03 | メディミューン リミテッド | 変異型Ｆｃ領域を含むモノマーポリペプチド及び使用方法 |
| WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
| EP3556396B1 (en) | 2010-08-31 | 2022-04-20 | Theraclone Sciences, Inc. | Human immunodeficiency virus (hiv)-neutralizing antibodies |
| WO2012092539A2 (en) | 2010-12-31 | 2012-07-05 | Takeda Pharmaceutical Company Limited | Antibodies to dll4 and uses thereof |
| TW201245223A (en) | 2011-02-14 | 2012-11-16 | Theraclone Sciences Inc | Compositions and methods for the therapy and diagnosis of influenza |
| WO2012125614A1 (en) | 2011-03-15 | 2012-09-20 | Theraclone Sciences, Inc. | Compositions and methods for the therapy and diagnosis of influenza |
| CN109734807A (zh) | 2011-03-31 | 2019-05-10 | 豪夫迈·罗氏有限公司 | 施用β7整联蛋白拮抗剂的方法 |
| BR112013028907A2 (pt) | 2011-05-08 | 2017-01-31 | Legochem Biosciences Inc | conjugados de proteína-agente ativo e método para preparar os mesmos |
| CA2836468C (en) | 2011-05-17 | 2021-05-04 | The Rockefeller University | Human immunodeficiency virus neutralizing antibodies and methods of use thereof |
| WO2012170071A1 (en) | 2011-06-06 | 2012-12-13 | Elan Pharmaceuticas, Inc | Mcam antagonists and methods of treatment |
| JP2013040160A (ja) | 2011-07-01 | 2013-02-28 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| US9120858B2 (en) | 2011-07-22 | 2015-09-01 | The Research Foundation Of State University Of New York | Antibodies to the B12-transcobalamin receptor |
| WO2013015821A1 (en) | 2011-07-22 | 2013-01-31 | The Research Foundation Of State University Of New York | Antibodies to the b12-transcobalamin receptor |
| US9890207B2 (en) | 2011-07-25 | 2018-02-13 | California Institute Of Technology | Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 |
| US9493549B2 (en) | 2011-07-25 | 2016-11-15 | The Rockefeller University | Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth |
| WO2013033069A1 (en) | 2011-08-30 | 2013-03-07 | Theraclone Sciences, Inc. | Human rhinovirus (hrv) antibodies |
| JP6684490B2 (ja) | 2012-01-09 | 2020-04-22 | ザ・スクリップス・リサーチ・インスティテュート | 超長相補性決定領域及びその使用 |
| EP3663314A1 (en) | 2012-01-09 | 2020-06-10 | The Scripps Research Institute | Humanized antibodies with ultralong cdr3s |
| JP2015506950A (ja) | 2012-01-31 | 2015-03-05 | ジェネンテック， インコーポレイテッド | 抗ｉｇ−ｅｍ１’抗体およびそれを用いる方法 |
| RU2014136886A (ru) | 2012-03-27 | 2016-05-20 | Дженентек, Инк. | Диагностика и виды лечения, связанные с ингибиторами her3 |
| WO2013148232A1 (en) | 2012-03-27 | 2013-10-03 | Genentech, Inc. | Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| WO2013192589A1 (en) | 2012-06-21 | 2013-12-27 | California Institute Of Technology | Antibodies targeting hiv escape mutants |
| WO2014018375A1 (en) | 2012-07-23 | 2014-01-30 | Xenon Pharmaceuticals Inc. | Cyp8b1 and uses thereof in therapeutic and diagnostic methods |
| AU2013306098A1 (en) | 2012-08-18 | 2015-02-12 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
| WO2014031762A1 (en) | 2012-08-21 | 2014-02-27 | Academia Sinica | Benzocyclooctyne compounds and uses thereof |
| TWI595007B (zh) | 2012-09-10 | 2017-08-11 | Neotope Biosciences Ltd | 抗ｍｃａｍ抗體及相關使用方法 |
| RU2015112024A (ru) | 2012-10-05 | 2016-11-27 | Дженентек, Инк. | Способы диагностики и лечения воспалительного заболевания кишечника |
| PL2908912T3 (pl) | 2012-10-18 | 2021-05-17 | The Rockefeller University | Szeroko neutralizujące przeciwciała anty-hiv |
| JP6348115B2 (ja) | 2012-10-26 | 2018-06-27 | ザ ユニバーシティー オブ クイーンズランド | がん療法のためのエンドサイトーシス阻害剤および抗体の使用 |
| CN105143876B (zh) | 2013-03-27 | 2018-04-20 | 豪夫迈·罗氏有限公司 | 生物标志物用于评估用β7整联蛋白拮抗剂治疗胃肠炎性病症的用途 |
| EP2983710B1 (en) | 2013-04-09 | 2019-07-31 | Annexon, Inc. | Methods of treatment for neuromyelitis optica |
| WO2014210397A1 (en) | 2013-06-26 | 2014-12-31 | Academia Sinica | Rm2 antigens and use thereof |
| US9981030B2 (en) | 2013-06-27 | 2018-05-29 | Academia Sinica | Glycan conjugates and use thereof |
| KR102321320B1 (ko) | 2013-07-09 | 2021-11-03 | 애넥슨, 인코포레이티드 | 항-보체 인자 ｃ１ｑ 항체 및 이의 용도 |
| EP3022224A2 (en) | 2013-07-18 | 2016-05-25 | Fabrus, Inc. | Antibodies with ultralong complementarity determining regions |
| CA2918370A1 (en) | 2013-07-18 | 2015-01-22 | Fabrus, Inc. | Humanized antibodies with ultralong complementarity determining regions |
| CN105682666B (zh) | 2013-09-06 | 2021-06-01 | 中央研究院 | 使用醣脂激活人类iNKT细胞 |
| WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
| BR112016011027A2 (pt) | 2013-12-20 | 2017-12-05 | Genentech Inc | método de produção de um anticorpo, anticorpos, composição farmacêutica, polinucleotídeo, vetor, célula hospedeira, método de tratamento de asma e método de tratamento de um distúrbio |
| US10266586B2 (en) | 2014-01-14 | 2019-04-23 | The Medical College Of Wisconsin, Inc. | Targeting CLPTM1L for treatment and prevention of cancer |
| EP3094352B1 (en) | 2014-01-16 | 2020-09-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| WO2015116902A1 (en) | 2014-01-31 | 2015-08-06 | Genentech, Inc. | G-protein coupled receptors in hedgehog signaling |
| WO2015148915A1 (en) | 2014-03-27 | 2015-10-01 | Academia Sinica | Reactive labelling compounds and uses thereof |
| WO2015148809A1 (en) | 2014-03-27 | 2015-10-01 | Genentech, Inc. | Methods for diagnosing and treating inflammatory bowel disease |
| CN104012547A (zh) * | 2014-05-07 | 2014-09-03 | 广东中迅农科股份有限公司 | 一种含有双唑草腈和氰氟草酯的除草组合物 |
| CN104012549B (zh) * | 2014-05-07 | 2016-08-17 | 广东中迅农科股份有限公司 | 一种含有双唑草腈和双草醚的除草组合物 |
| WO2015175874A2 (en) | 2014-05-16 | 2015-11-19 | Medimmune, Llc | Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties |
| IL249188B2 (en) | 2014-05-27 | 2024-03-01 | Academia Sinica | Anti-her2 glycoantibodies and uses thereof |
| KR20170003720A (ko) | 2014-05-27 | 2017-01-09 | 아카데미아 시니카 | 항-ｃｄ20 글리코항체 및 이의 용도 |
| KR20170010003A (ko) | 2014-05-27 | 2017-01-25 | 아카데미아 시니카 | 박테로이드 기원의 푸코시다제 및 이의 사용 방법 |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| CN106714829A (zh) | 2014-05-28 | 2017-05-24 | 中央研究院 | 抗TNF‑α醣抗体及其用途 |
| HUE047113T2 (hu) | 2014-05-30 | 2020-04-28 | Henlix Biotech Co Ltd | Epidermális növekedési faktor receptora (EGFR) elleni antitestek |
| SG11201700901SA (en) | 2014-08-08 | 2017-03-30 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
| CA2960712A1 (en) | 2014-09-08 | 2016-03-17 | Academia Sinica | Human inkt cell activation using glycolipids |
| CN104255750A (zh) * | 2014-09-10 | 2015-01-07 | 广东中迅农科股份有限公司 | 含有双唑草腈和丙草胺的除草组合物 |
| WO2016073157A1 (en) | 2014-11-06 | 2016-05-12 | Genentech, Inc. | Anti-ang2 antibodies and methods of use thereof |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| AU2016208585A1 (en) | 2015-01-22 | 2017-08-03 | BASF Agro B.V. | Ternary herbicidal combination comprising saflufenacil |
| CA2972072A1 (en) | 2015-01-24 | 2016-07-28 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
| EP3250927B1 (en) | 2015-01-28 | 2020-02-19 | H. Hoffnabb-La Roche Ag | Gene expression markers and treatment of multiple sclerosis |
| MX2017010336A (es) | 2015-02-26 | 2017-12-20 | Genentech Inc | Antagonistas de integrina beta7 y métodos para el tratamiento de la enfermedad de crohn. |
| MX2017012352A (es) | 2015-04-03 | 2018-01-26 | Eureka Therapeutics Inc | Construccion dirigida a complejos de peptido de alfa-fetoproteina/complejo principal de histocompatibilidad (afp/cph) y usos de los mismos. |
| ES2899227T3 (es) | 2015-04-07 | 2022-03-10 | Alector Llc | Anticuerpos anti sortilina y métodos de uso de los mismos |
| CN104757013A (zh) * | 2015-04-18 | 2015-07-08 | 广东中迅农科股份有限公司 | 含有双唑草腈和四唑酰草胺及精噁唑禾草灵的除草组合物 |
| CA3026154A1 (en) | 2015-06-03 | 2016-12-08 | The University Of Queensland | Mobilizing agents and uses therefor |
| CA2988982A1 (en) | 2015-06-12 | 2016-12-15 | Alector Llc | Anti-cd33 antibodies and methods of use thereof |
| HK1252675A1 (zh) | 2015-06-12 | 2019-05-31 | Alector Llc | 抗cd33抗体及其使用方法 |
| CN107708422A (zh) | 2015-07-10 | 2018-02-16 | 巴斯夫农业公司 | 防治除草剂抗性或耐受性杂草的方法 |
| BR112018000482B1 (pt) | 2015-07-10 | 2022-11-22 | BASF Agro B.V. | Composição herbicida, uso da composição e método para o controle da vegetação indesejada |
| US11219215B2 (en) | 2015-07-10 | 2022-01-11 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and specific inhibitors of protoporphyrinogen oxidase |
| KR20180027580A (ko) * | 2015-07-10 | 2018-03-14 | 바스프 아그로 비.브이. | 신메틸린 및 특정한 퀴놀린카르복실산을 포함하는 제초제 조성물 |
| AU2016294380B2 (en) | 2015-07-10 | 2020-12-24 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and pyroxasulfone |
| LT3319434T (lt) | 2015-07-10 | 2019-07-10 | BASF Agro B.V. | Herbicidinė kompozicija, apimanti cinmetiliną ir petoksamidą |
| US11219212B2 (en) | 2015-07-10 | 2022-01-11 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and imazamox |
| PL3319435T3 (pl) | 2015-07-10 | 2020-07-27 | BASF Agro B.V. | Kompozycja chwastobójcza zawierająca cynmetalinę i chlomazon |
| US20180192647A1 (en) | 2015-07-10 | 2018-07-12 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and acetochlor or pretilachlor |
| US10813356B2 (en) | 2015-07-10 | 2020-10-27 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and dimethenamid |
| CN105076162B (zh) * | 2015-08-05 | 2018-03-09 | 安徽华星化工有限公司 | 一种含有乙氧氟草醚和双唑草腈的水稻田除草组合物 |
| HK1252696A1 (zh) | 2015-08-28 | 2019-05-31 | 艾利妥 | 抗siglec-7抗体及其使用方法 |
| CA2997960A1 (en) | 2015-10-06 | 2017-04-13 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
| MY194628A (en) | 2015-10-23 | 2022-12-07 | Eureka Therapeutics Inc | Antibody/t-cell receptor chimeric constructs and uses thereof |
| AU2016343987B2 (en) | 2015-10-29 | 2023-11-23 | Alector Llc | Anti-Siglec-9 antibodies and methods of use thereof |
| CA3006242A1 (en) | 2015-11-25 | 2017-06-01 | Legochem Biosciences, Inc. | Conjugates comprising self-immolative groups and methods related thereto |
| ES3038408T3 (en) | 2015-12-30 | 2025-10-13 | Hoffmann La Roche | Formulations with reduced degradation of polysorbate |
| EP3423493A2 (en) | 2016-03-04 | 2019-01-09 | Alector LLC | Anti-trem1 antibodies and methods of use thereof |
| WO2017156192A1 (en) | 2016-03-08 | 2017-09-14 | Academia Sinica | Methods for modular synthesis of n-glycans and arrays thereof |
| CN105901005A (zh) * | 2016-05-16 | 2016-08-31 | 河北博嘉农业有限公司 | 一种含有双唑草腈的除草组合物 |
| CN105918339A (zh) * | 2016-05-19 | 2016-09-07 | 河北博嘉农业有限公司 | 一种含有双唑草腈和磺酰脲类除草剂的除草组合物 |
| WO2018014260A1 (en) | 2016-07-20 | 2018-01-25 | Nanjing Legend Biotech Co., Ltd. | Multispecific antigen binding proteins and methods of use thereof |
| TWI764917B (zh) | 2016-08-22 | 2022-05-21 | 醣基生醫股份有限公司 | 抗體、結合片段及使用方法 |
| DK4339615T3 (da) | 2016-09-16 | 2025-12-22 | Shanghai Henlius Biotech Inc | Anti-PD-1-antistof til anvendelse i behandlingen af kræft |
| WO2018068201A1 (en) | 2016-10-11 | 2018-04-19 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies and variants thereof against ctla-4 |
| CN108064871A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN108064866A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN108064868A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN108064860A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN106561695A (zh) * | 2016-11-15 | 2017-04-19 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN108064865A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| KR102085798B1 (ko) | 2016-12-28 | 2020-03-06 | 주식회사 인투셀 | 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물 |
| WO2018132597A1 (en) | 2017-01-12 | 2018-07-19 | Eureka Therapeutics, Inc. | Constructs targeting histone h3 peptide/mhc complexes and uses thereof |
| WO2018152496A1 (en) | 2017-02-17 | 2018-08-23 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Compositions and methods for the diagnosis and treatment of zika virus infection |
| CN106857609A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与乙氧嘧磺隆的除草组合物及其应用 |
| CN107047592A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与苄嘧磺隆的除草组合物及其应用 |
| CN106889083B (zh) * | 2017-02-27 | 2019-02-12 | 南京华洲药业有限公司 | 一种含双唑草腈与异恶草酮的除草组合物及其应用 |
| CN106889094A (zh) * | 2017-02-27 | 2017-06-27 | 南京华洲药业有限公司 | 一种含双唑草腈与吡嘧磺隆的除草组合物及其应用 |
| CN107047578A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与丙炔噁草酮的除草组合物及其应用 |
| CN106857577A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与氟硫草定的除草组合物及其应用 |
| CN106889084A (zh) * | 2017-02-27 | 2017-06-27 | 南京华洲药业有限公司 | 一种含双唑草腈与灭草松的除草组合物及其应用 |
| CN106857575A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与丁草胺的除草组合物及其应用 |
| CN106857579A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与三嗪氟草胺的除草组合物及其应用 |
| CN106857578A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与乙草胺的除草组合物及其应用 |
| CN106857600A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与异丙隆的除草组合物及其应用 |
| CN106857580A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与吡氟酰草胺的除草组合物及其应用 |
| CN106889082A (zh) * | 2017-02-27 | 2017-06-27 | 南京华洲药业有限公司 | 一种含双唑草腈与噁草酮的除草组合物及其应用 |
| CN106857621A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与禾草敌的除草组合物及其应用 |
| CN106857576A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与苯噻酰草胺的除草组合物及其应用 |
| CN107047594A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与氯吡嘧磺隆的除草组合物及其应用 |
| CN107047593A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与乙氧磺隆的除草组合物及其应用 |
| CN107047582A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与禾草畏的除草组合物及其应用 |
| RU2665790C1 (ru) | 2017-04-17 | 2018-09-04 | Закрытое Акционерное Общество "Биокад" | Моноклональное антитело к pd-l1 |
| WO2018200742A1 (en) | 2017-04-25 | 2018-11-01 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Antibodies and methods for the diagnosis and treatment of epstein barr virus infection |
| AU2018258045B2 (en) | 2017-04-26 | 2024-02-29 | Eureka Therapeutics, Inc. | Chimeric antibody/T-cell receptor constructs and uses thereof |
| SG10201913582XA (en) | 2017-04-26 | 2020-02-27 | Eureka Therapeutics Inc | Constructs specifically recognizing glypican 3 and uses thereof |
| US11359014B2 (en) | 2017-05-16 | 2022-06-14 | Alector Llc | Anti-siglec-5 antibodies and methods of use thereof |
| CN107114382A (zh) * | 2017-05-22 | 2017-09-01 | 娄天成 | 一种含双唑草腈和敌稗的农药组合物及其应用 |
| CN107094781A (zh) * | 2017-05-22 | 2017-08-29 | 孙金金 | 一种含双唑草腈和二氯喹啉酸的农药组合物及其应用 |
| CN106954634A (zh) * | 2017-05-22 | 2017-07-18 | 娄天成 | 一种含双唑草腈和莎稗磷的农药组合物及其应用 |
| US11530273B2 (en) | 2017-05-23 | 2022-12-20 | Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Anti-CD73 monoclonal antibody, encoding nucleic acids and method for producing |
| CN107006498A (zh) * | 2017-05-24 | 2017-08-04 | 江苏省农用激素工程技术研究中心有限公司 | 用于防除稻田杂草的除草组合物 |
| RU2653545C1 (ru) * | 2017-07-17 | 2018-05-11 | АО "Щелково Агрохим" | Гербицидная композиция на основе бентазона для защиты зернобобовых культур |
| EP3655430A1 (en) | 2017-07-19 | 2020-05-27 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection |
| BR112019023789A2 (pt) | 2017-08-03 | 2020-07-28 | Alector Llc | anticorpos anti-cd33 e métodos de uso dos mesmos |
| CN119192376A (zh) | 2017-08-03 | 2024-12-27 | 艾利妥 | 抗trem2抗体和其使用方法 |
| RU2698048C2 (ru) | 2017-10-03 | 2019-08-21 | Закрытое Акционерное Общество "Биокад" | МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα |
| EA039662B1 (ru) | 2017-10-03 | 2022-02-24 | Закрытое Акционерное Общество "Биокад" | Антитела, специфичные к cd47 и pd-l1 |
| AU2018388791B2 (en) | 2017-12-19 | 2025-04-03 | The Rockefeller University | Human IgG Fc domain variants with improved effector function |
| JP7369127B2 (ja) | 2017-12-28 | 2023-10-25 | ナンジン レジェンド バイオテック カンパニー，リミテッド | Ｔｉｇｉｔに対する単一ドメイン抗体及びその変異体 |
| US11713353B2 (en) | 2018-01-15 | 2023-08-01 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies and variants thereof against PD-1 |
| BR112020013405A2 (pt) | 2018-01-25 | 2020-12-01 | Acm Biolabs Pte Ltd. | polimerossomas compreendendo um antígeno encapsulado solúvel, assim como métodos de sua fabricação e uso |
| CN108371183A (zh) * | 2018-02-02 | 2018-08-07 | 河北中天邦正生物科技股份公司 | 一种农药组合物及其应用 |
| CN108308187A (zh) * | 2018-02-11 | 2018-07-24 | 河北中天邦正生物科技股份公司 | 一种农药组合物及其应用 |
| EP3774917B1 (en) | 2018-03-30 | 2025-10-29 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies against lag-3 and uses thereof |
| EP3788071A1 (en) | 2018-05-02 | 2021-03-10 | The United States Of America, As Represented By The Secretary, Department of Health and Human Services | Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection |
| JP7382970B2 (ja) | 2018-06-08 | 2023-11-17 | アレクトル エルエルシー | 抗Ｓｉｇｌｅｃ－７抗体及びその使用方法 |
| CN112469440B (zh) | 2018-06-18 | 2024-09-06 | 优瑞科生物技术公司 | 靶向前列腺特异性膜抗原(psma)的构建体和其用途 |
| US20210275589A1 (en) | 2018-07-13 | 2021-09-09 | Nanjing Legend Biotech Co. Ltd. | Co-receptor systems for treating infectious diseases |
| KR102530517B1 (ko) | 2018-07-13 | 2023-05-09 | 알렉터 엘엘씨 | 항-소틸린 항체 및 이들의 사용 방법 |
| BR112021001451A2 (pt) | 2018-07-27 | 2021-04-27 | Alector Llc | anticorpos monoclonais anti-siglec-5 isolados, ácido nucleico, vetor, célula hospedeira, métodos de produção de um anticorpo e de prevenção, composição farmacêutica e métodos para induzir ou promover a sobrevida, para diminuir a atividade, para diminuir os níveis celulares, para induzir a produção de espécies reativas, para induzir a formação de neutrophil extracellular trap (net), para induzir a ativação de neutrófilos, para atenuar um ou mais neutrófilos imunossuprimidos e para aumentar a atividade de fagocitose |
| AR119259A1 (es) | 2018-08-31 | 2021-12-09 | Alector Llc | Anticuerpos anti-cd33 y métodos de uso de los mismos |
| WO2020053325A1 (en) | 2018-09-12 | 2020-03-19 | Acm Biolabs Pte Ltd | Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof |
| WO2020056145A1 (en) | 2018-09-14 | 2020-03-19 | The Rockefeller University | Anti-hiv antibody 10-1074 variants |
| US12129305B2 (en) | 2018-10-25 | 2024-10-29 | The Medical College Of Wisconsin, Inc. | Targeting CLPTM1L for treatment and prevention of cancer |
| RU2724469C2 (ru) | 2018-10-31 | 2020-06-23 | Закрытое Акционерное Общество "Биокад" | Моноклональное антитело, которое специфически связывается с cd20 |
| US12168696B2 (en) | 2018-11-16 | 2024-12-17 | Memorial Sloan Kettering Cancer Center | Antibodies to mucin-16 (MUC16), encoding polynucleotides and methods of treating MUC16-positive cancer |
| WO2020108423A1 (en) | 2018-11-27 | 2020-06-04 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies specifically recognizing granulocyte-macrophage colony stimulating factor receptor alpha and uses thereof |
| RU2734432C1 (ru) | 2019-04-23 | 2020-10-16 | Закрытое Акционерное Общество "Биокад" | Моноклональное антитело, которое специфически связывается с GITR |
| WO2020222573A1 (ko) | 2019-05-02 | 2020-11-05 | 주식회사 레고켐 바이오사이언스 | 트리스 구조를 가지는 링커를 포함하는 리간드-약물 접합체 |
| AU2020304649B2 (en) | 2019-06-28 | 2025-09-04 | Genentech, Inc. | Composition and methods for stabilizing liquid protein formulations |
| CN110178842A (zh) * | 2019-07-05 | 2019-08-30 | 南京农业大学 | 一种丙草胺与双唑草腈治理抗性稗组合物及其应用 |
| WO2021004446A1 (en) | 2019-07-09 | 2021-01-14 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies specifically recognizing pseudomonas pcrv and uses thereof |
| MX2022000726A (es) | 2019-07-19 | 2022-02-10 | Oncoresponse Inc | Anticuerpos inmunomoduladores y metodos de uso de los mismos. |
| CN112300279A (zh) | 2019-07-26 | 2021-02-02 | 上海复宏汉霖生物技术股份有限公司 | 针对抗cd73抗体和变体的方法和组合物 |
| WO2021238886A1 (en) | 2020-05-27 | 2021-12-02 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies specifically recognizing nerve growth factor and uses thereof |
| MX2023008485A (es) | 2021-01-20 | 2023-07-28 | Oncoresponse Inc | Anticuerpos inmunomoduladores y usos de estos. |
| US20250281405A1 (en) | 2021-04-12 | 2025-09-11 | Acm Biolabs Pte Ltd | Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof |
| CN118103397A (zh) | 2021-07-08 | 2024-05-28 | 舒泰神(加州)生物科技有限公司 | 特异性识别tnfr2的抗体及其用途 |
| EP4371572A4 (en) | 2021-07-14 | 2025-08-06 | Staidson Beijing Biopharmaceuticals Co Ltd | ANTIBODY SPECIFICALLY RECOGNIZING CD40 AND ITS APPLICATION |
| US20250066458A1 (en) | 2021-12-06 | 2025-02-27 | Beijing Solobio Genetechnology Co., Ltd. | Bispecific Antibodies Specifically Binding to Klebsiella Pneumoniae O2 Antigen and O1 Antigen and Compositions Thereof |
| US20250326828A1 (en) | 2022-05-09 | 2025-10-23 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies Specifically Recognizing Gdf15 and Uses Thereof |
| CN120322455A (zh) | 2022-07-19 | 2025-07-15 | 舒泰神(加州)生物科技有限公司 | 特异性识别b和t淋巴细胞衰减器(btla)的抗体及其应用 |
| EP4596580A1 (en) | 2022-09-27 | 2025-08-06 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibody for specifically recognizing light and use thereof |
| EP4606886A1 (en) | 2022-10-20 | 2025-08-27 | Beijing SoloBio Genetechnology Company Ltd. | Antibody combination specifically binding to trail or fasl, and bispecific antibody |
| WO2025224166A1 (en) | 2024-04-23 | 2025-10-30 | F. Hoffmann-La Roche Ag | Anti-drug antibody assays |
| WO2025233867A1 (en) | 2024-05-10 | 2025-11-13 | Adaptam Therapeutics, S.L. | Anti-siglec-9 antibodies and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY136106A (en) * | 1990-09-06 | 2008-08-29 | Novartis Ag | Synergistic composition comprising a sulfonylurea anda thiadiazolo (3,4-a)pyridazine and method of selective weed control. |
| IL103678A (en) * | 1991-11-13 | 1996-09-12 | Schering Ag | History of pyrazolylpyrazole, processes for their preparation and herbicidal preparations containing them |
| HU219150B (hu) * | 1992-10-12 | 2001-02-28 | Schering Ag. | Új szubsztituált pirazolszármazékok, eljárás azok előállítására, valamint herbicidként történő alkalmazásuk |
-
1995
- 1995-11-15 DE DE19544393A patent/DE19544393A1/de not_active Withdrawn
-
1996
- 1996-11-12 US US09/068,137 patent/US6013605A/en not_active Expired - Lifetime
- 1996-11-12 JP JP51856597A patent/JP3920341B2/ja not_active Expired - Lifetime
- 1996-11-12 CN CN96198102A patent/CN1084148C/zh not_active Expired - Lifetime
- 1996-11-12 KR KR10-1998-0703305A patent/KR100427960B1/ko not_active Expired - Lifetime
- 1996-11-12 CA CA002236592A patent/CA2236592C/en not_active Expired - Lifetime
- 1996-11-12 EP EP96938177A patent/EP0863705B1/de not_active Expired - Lifetime
- 1996-11-12 TR TR1998/00794T patent/TR199800794T2/xx unknown
- 1996-11-12 RU RU98111619/04A patent/RU2170017C2/ru not_active IP Right Cessation
- 1996-11-12 DE DE59609348T patent/DE59609348D1/de not_active Expired - Fee Related
- 1996-11-12 WO PCT/EP1996/004935 patent/WO1997017852A1/de not_active Ceased
- 1996-11-12 AU AU75696/96A patent/AU711841B2/en not_active Expired
- 1996-11-12 ES ES96938177T patent/ES2178720T3/es not_active Expired - Lifetime
- 1996-11-12 BR BR9611478A patent/BR9611478A/pt not_active IP Right Cessation
- 1996-11-13 TW TW085113810A patent/TW355125B/zh not_active IP Right Cessation
- 1996-11-13 MY MYPI96004700A patent/MY114731A/en unknown
- 1996-11-14 ZA ZA969564A patent/ZA969564B/xx unknown
- 1996-12-11 UA UA98063093A patent/UA48203C2/uk unknown
-
1998
- 1998-05-14 MX MX9803824A patent/MX9803824A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990067314A (ko) | 1999-08-16 |
| CN1201370A (zh) | 1998-12-09 |
| CA2236592C (en) | 2005-01-04 |
| KR100427960B1 (ko) | 2005-01-15 |
| AU7569696A (en) | 1997-06-05 |
| RU2170017C2 (ru) | 2001-07-10 |
| MX9803824A (es) | 1998-09-30 |
| AU711841B2 (en) | 1999-10-21 |
| CN1084148C (zh) | 2002-05-08 |
| CA2236592A1 (en) | 1997-05-22 |
| JP2000500445A (ja) | 2000-01-18 |
| ZA969564B (en) | 1997-05-15 |
| WO1997017852A1 (de) | 1997-05-22 |
| UA48203C2 (uk) | 2002-08-15 |
| MY114731A (en) | 2002-12-31 |
| EP0863705A1 (de) | 1998-09-16 |
| ES2178720T3 (es) | 2003-01-01 |
| US6013605A (en) | 2000-01-11 |
| TW355125B (en) | 1999-04-01 |
| DE19544393A1 (de) | 1997-05-22 |
| DE59609348D1 (de) | 2002-07-18 |
| BR9611478A (pt) | 1999-07-13 |
| EP0863705B1 (de) | 2002-06-12 |
| TR199800794T2 (xx) | 1998-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3920341B2 (ja) | 相乗作用除草剤混合物 | |
| KR101068773B1 (ko) | 제초제 조성물 | |
| JP4594525B2 (ja) | 除草剤 | |
| RU2286059C2 (ru) | Синергитическая гербицидная композиция, способ борьбы с нежелательной растительностью | |
| DK2170052T3 (en) | Synergistic CULTURE PLANT SETTLEMENT RIGHT COMBINATION CONTAINING HERBICIDES FROM THE GROUP OF benzoyl cyclohexanediones FOR USE IN RISKULTURER | |
| KR100755578B1 (ko) | 하이드록시페닐피루베이트 디옥시게나제 억제제로이루어진 군에서 선택되는 제초제를 포함하는 상승적제초제 조성물 | |
| KR100827154B1 (ko) | 쌀 경작에 살포하기 위한 벤조일사이클로헥산디온을포함하는 상승효과적 제초제 | |
| PT2033521E (pt) | Combinações herbicidas com sulfonilureias especiais | |
| KR20050085096A (ko) | 제초제 조성물 | |
| CA3078669C (en) | HERBICIDAL COMPOSITION WITH SYNERGISTIC EFFICACY COMPRISING PELARGONIC ACID AND FLAZASULFURON | |
| RU2266647C2 (ru) | Гербицидное средство, способ его получения и способ борьбы с вредными растениями | |
| KR100932394B1 (ko) | 제초 조성물 | |
| KR20050044551A (ko) | 벤조일피라졸 그룹으로부터의 제초제를 함유하는상승효과적 제초제 | |
| KR100827155B1 (ko) | 쌀 경작에 살포하기 위한 벤조일사이클로헥산디온을포함하는 상승효과적 제초제 | |
| US6239070B1 (en) | Herbicidal mixtures | |
| KR100320834B1 (ko) | 상승작용성 제초제 및 독성완화제 | |
| US4530717A (en) | Synergistic herbicidal mixtures of substituted phenylsulfonylurea derivatives and benzthiazol-2-yl-oxyacetic acid N-methylanilide | |
| HK1041417A1 (zh) | 以取代的苯基磺酰基氨基羰基三唑啉酮為基礎的選擇性除草劑 | |
| JP4708349B2 (ja) | 水田用除草剤組成物 | |
| JP3300008B2 (ja) | 除草剤組成物、および雑草を防除する方法 | |
| KR0166975B1 (ko) | 벤푸레세이트 및 다임론을 기재로 하는 제초 조성물 | |
| CA2473585A1 (en) | Herbicidal composition | |
| EP0890311A2 (en) | Herbicidal mixtures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20050118 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061010 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061208 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070130 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070215 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110223 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110223 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120223 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120223 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130223 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130223 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |